[{"address1": "930 Winter Street", "address2": "Suite M-500", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "617 443 2400", "website": "https://www.aerovatetx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aerovate Therapeutics, Inc., a biopharmaceutical company, engages in the treatment of pulmonary arterial hypertension in the United States. Aerovate Therapeutics, Inc., was incorporated in 2018 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Mr. Timothy P. Noyes M.B.A.", "age": 62, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 936899, "exercisedValue": 0, "unexercisedValue": 10446414}, {"maxAge": 1, "name": "Mr. George A. Eldridge", "age": 61, "title": "CFO & Treasurer", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 658600, "exercisedValue": 0, "unexercisedValue": 1968391}, {"maxAge": 1, "name": "Dr. Benjamin T. Dake Ph.D.", "age": 48, "title": "Founder, President, COO & Secretary", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 435500, "exercisedValue": 0, "unexercisedValue": 975487}, {"maxAge": 1, "name": "Dr. Ralph W. Niven M.B.A., M.R, Ph.D., Pharm.S", "age": 64, "title": "Chief Scientific Officer", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 372333, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Hunter  Gillies M.D.", "age": 58, "title": "Chief Medical Officer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 512742, "exercisedValue": 0, "unexercisedValue": 313002}, {"maxAge": 1, "name": "Ms. Donna  Dea", "title": "Head of Regulatory Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Susan  Fischer", "title": "Executive Vice President of Development Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stephen K. Yu", "title": "Senior Vice President of Quality", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sanjeev  Khindri", "title": "Executive Vice President of Clinical Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cheryl  Lassen BSc., M.D., MBBCh", "title": "Senior Vice President of Clinical Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.68, "open": 2.66, "dayLow": 2.6296, "dayHigh": 2.77, "regularMarketPreviousClose": 2.68, "regularMarketOpen": 2.66, "regularMarketDayLow": 2.6296, "regularMarketDayHigh": 2.77, "exDividendDate": 1745539200, "payoutRatio": 0.0, "beta": 0.946, "forwardPE": -0.29450518, "volume": 981795, "regularMarketVolume": 981795, "averageVolume": 8479, "averageVolume10days": 31328, "averageDailyVolume10Day": 31328, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 77679800, "fiftyTwoWeekLow": 2.6296, "fiftyTwoWeekHigh": 884.975, "fiftyDayAverage": 88.739, "twoHundredDayAverage": 82.178246, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1781890, "profitMargins": 0.0, "floatShares": 341841, "sharesOutstanding": 28985000, "sharesShort": 131230, "sharesShortPriorMonth": 123124, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0045, "heldPercentInsiders": 0.00017000001, "heldPercentInstitutions": 1.1080201, "shortRatio": 26.71, "shortPercentOfFloat": 0.0115, "impliedSharesOutstanding": 29417600, "bookValue": 90.62, "priceToBook": 0.029574046, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -48960000, "trailingEps": -59.5, "forwardEps": -1.0, "lastSplitFactor": "1:35", "lastSplitDate": 1745884800, "enterpriseToEbitda": -0.034, "52WeekChange": -0.8599791, "SandP52WeekChange": 0.1189177, "lastDividendValue": 2.4, "lastDividendDate": 1745539200, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "AVTE", "underlyingSymbol": "AVTE", "shortName": "Aerovate Therapeutics, Inc.", "longName": "Aerovate Therapeutics, Inc.", "firstTradeDateEpochUtc": 1625059800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "cbf275de-3fc7-3baa-b402-2df34de7643f", "messageBoardId": "finmb_650355034", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.68, "targetHighPrice": 105.00011, "targetLowPrice": 70.00007, "targetMeanPrice": 81.66675, "targetMedianPrice": 70.00007, "recommendationMean": 3.0, "recommendationKey": "hold", "numberOfAnalystOpinions": 3, "totalCash": 76210000, "totalCashPerShare": 92.025, "ebitda": -53107000, "totalDebt": 312000, "quickRatio": 31.531, "currentRatio": 32.012, "debtToEquity": 0.416, "returnOnAssets": -0.36183998, "returnOnEquity": -0.59006, "freeCashflow": -35025124, "operatingCashflow": -49904000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-05-31"}]